Tejnaksh Healthcare Limited (BOM:539428)
India
· Delayed Price · Currency is INR 15.95
-0.01 (-0.06%)
At close: Apr 28, 2026
Tejnaksh Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 114.49 | 128.97 | 121.75 | 117.27 | 126.76 | 119.6 | Upgrade
|
| Other Revenue | 1.24 | 1.24 | 0.81 | 1.42 | 0.64 | - | Upgrade
|
| Revenue | 115.73 | 130.21 | 122.56 | 118.69 | 127.4 | 119.6 | Upgrade
|
| Revenue Growth (YoY) | -8.77% | 6.24% | 3.26% | -6.84% | 6.52% | -31.11% | Upgrade
|
| Cost of Revenue | 34.31 | 35.87 | 29.46 | 31.25 | 30.4 | 24.4 | Upgrade
|
| Gross Profit | 81.42 | 94.34 | 93.1 | 87.44 | 97 | 95.2 | Upgrade
|
| Selling, General & Admin | 0.22 | 0.22 | 0.58 | 0.34 | 0.21 | 0.12 | Upgrade
|
| Other Operating Expenses | 52.23 | 52.13 | 55.49 | 48.81 | 48.17 | 57.9 | Upgrade
|
| Operating Expenses | 64.89 | 61.45 | 65.12 | 57.89 | 55.03 | 64.83 | Upgrade
|
| Operating Income | 16.54 | 32.89 | 27.98 | 29.55 | 41.97 | 30.37 | Upgrade
|
| Interest Expense | -1.35 | -3.76 | -6.41 | -6.08 | -4.02 | -4.86 | Upgrade
|
| Interest & Investment Income | 1.5 | 1.5 | 2.05 | 1.33 | 0.62 | 0.56 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.04 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.55 | 1.31 | 0.17 | 0.31 | -0.52 | 0.66 | Upgrade
|
| EBT Excluding Unusual Items | 17.22 | 31.91 | 23.75 | 25.13 | 38.06 | 26.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.45 | -0.06 | Upgrade
|
| Pretax Income | 17.22 | 31.91 | 23.75 | 25.13 | 37.61 | 26.68 | Upgrade
|
| Income Tax Expense | 4.66 | 9.61 | 6.11 | 7.21 | 9.5 | 5.99 | Upgrade
|
| Earnings From Continuing Operations | 12.56 | 22.31 | 17.64 | 17.91 | 28.11 | 20.69 | Upgrade
|
| Minority Interest in Earnings | 1.2 | 0.97 | 0.12 | -1.09 | -0.88 | -0.16 | Upgrade
|
| Net Income | 13.76 | 23.28 | 17.76 | 16.83 | 27.24 | 20.53 | Upgrade
|
| Net Income to Common | 13.76 | 23.28 | 17.76 | 16.83 | 27.24 | 20.53 | Upgrade
|
| Net Income Growth | -39.57% | 31.07% | 5.54% | -38.22% | 32.67% | -1.78% | Upgrade
|
| Shares Outstanding (Basic) | 21 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 20 | 20 | 20 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | 13.09% | - | - | - | - | 0.00% | Upgrade
|
| EPS (Basic) | 0.65 | 1.15 | 0.87 | 0.83 | 1.34 | 1.01 | Upgrade
|
| EPS (Diluted) | 0.65 | 1.15 | 0.87 | 0.83 | 1.34 | 1.01 | Upgrade
|
| EPS Growth | -46.56% | 31.07% | 5.54% | -38.22% | 32.67% | -1.78% | Upgrade
|
| Free Cash Flow | - | 1.35 | 33.03 | 12.96 | 1.31 | 7.39 | Upgrade
|
| Free Cash Flow Per Share | - | 0.07 | 1.63 | 0.64 | 0.06 | 0.36 | Upgrade
|
| Gross Margin | 70.36% | 72.46% | 75.96% | 73.67% | 76.14% | 79.60% | Upgrade
|
| Operating Margin | 14.29% | 25.26% | 22.83% | 24.90% | 32.94% | 25.40% | Upgrade
|
| Profit Margin | 11.89% | 17.88% | 14.49% | 14.18% | 21.38% | 17.16% | Upgrade
|
| Free Cash Flow Margin | - | 1.04% | 26.95% | 10.92% | 1.03% | 6.18% | Upgrade
|
| EBITDA | 25.55 | 41.84 | 36.84 | 38.07 | 48.27 | 37.13 | Upgrade
|
| EBITDA Margin | 22.08% | 32.13% | 30.06% | 32.07% | 37.88% | 31.04% | Upgrade
|
| D&A For EBITDA | 9.02 | 8.95 | 8.86 | 8.51 | 6.3 | 6.75 | Upgrade
|
| EBIT | 16.54 | 32.89 | 27.98 | 29.55 | 41.97 | 30.37 | Upgrade
|
| EBIT Margin | 14.29% | 25.26% | 22.83% | 24.90% | 32.94% | 25.40% | Upgrade
|
| Effective Tax Rate | 27.07% | 30.11% | 25.73% | 28.70% | 25.25% | 22.44% | Upgrade
|
| Revenue as Reported | 117.78 | 133.01 | 124.82 | 120.34 | 128.23 | 120.99 | Upgrade
|
| Advertising Expenses | - | 0.2 | 0.57 | 0.26 | 0.12 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.